Is Fusen Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Fusen Pharmaceutical pays dividends. Last time was Thursday 30th of June 2022 where the investors holding the stock on Tuesday 7th of June 2022 were paid HKD0.0042 per share. Over the last 8 times between 2018 and 2022, Fusen Pharmaceutical has paid HKD0.0436 with an average of HKD0.01 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Fusen Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD5.49, you would have made a loss of HKD-4.49 per share or -81.79%
No, the average daily trading liquidity for Fusen Pharmaceutical is HKD31 548 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Fusen Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Fusen Pharmaceutical to be high [0.75 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.